Deng-ren Ji
Beijing, 100083, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Intermedin Inhibits DNA Damage-Promoted Senescent Phenotype Transition of Vascular Smooth Muscle Cells in Aorta by Activating NAMPT/PARP1 in Mice.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 25, 2025
Intermedin1-53 improves aging-associated cardiac remodeling and dysfunction via mitochondrial SIRT3-mediated SOD2 deacetylation.
Journal: Journal of molecular and cellular cardiology
Published: December 26, 2024
Intermedin Alleviates Diabetic Cardiomyopathy by Up-Regulating CPT-1β through Activation of the Phosphatidyl Inositol 3 Kinase/Protein Kinase B Signaling Pathway.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 28, 2024
Intermedin alleviates diabetic vascular calcification by inhibiting GLUT1 through activation of the cAMP/PKA signaling pathway.
Journal: Atherosclerosis
Published: September 02, 2022
Intermedin Alleviates Vascular Calcification in CKD through Sirtuin 3-Mediated Inhibition of Mitochondrial Oxidative Stress.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 29, 2022
Plasma Level of Elabela in Patients with Coronary Heart Disease and Its Correlation with the Disease Classification.
Journal: International heart journal
Published: July 19, 2021
STAT3 Promotes Schistosome-Induced Liver Injury by Inflammation, Oxidative Stress, Proliferation, and Apoptosis Signal Pathway.
Journal: Infection and immunity
Published: May 26, 2020
New research advances in relationship of endoplasmic reticulum stress and cardiovascular diseases
Journal: Sheng li xue bao : [Acta physiologica Sinica]
Published: April 25, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026